JW (Cayman) Therapeutics Co. Ltd (JWCTF)
OTCMKTS
· Delayed Price · Currency is USD
0.1620
0.00 (0.00%)
May 1, 2025, 4:00 PM EDT
JWCTF Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Net Income | - | -768 | -846.14 | -702.33 | -1,664 | Upgrade
|
| Depreciation & Amortization | - | 93.77 | 81.37 | 46.33 | 23.17 | Upgrade
|
| Other Amortization | - | 6.06 | 5.71 | 1.9 | 0.42 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.93 | 0.17 | 0.12 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 181.21 | - | - | - | Upgrade
|
| Stock-Based Compensation | - | 34.97 | 82.5 | 89.37 | 134.25 | Upgrade
|
| Other Operating Activities | - | 49.45 | 164.76 | -46.37 | 1,228 | Upgrade
|
| Change in Accounts Receivable | - | 5.31 | -5.31 | - | - | Upgrade
|
| Change in Inventory | - | 5.38 | -8.76 | -28.78 | -0.96 | Upgrade
|
| Change in Other Net Operating Assets | - | -7.5 | -11.03 | 78.57 | 17.63 | Upgrade
|
| Operating Cash Flow | - | -398.42 | -536.72 | -561.2 | -261.01 | Upgrade
|
| Capital Expenditures | - | -12.41 | -76.87 | -73.09 | -124.24 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.08 | 0.05 | - | - | Upgrade
|
| Cash Acquisitions | - | - | - | - | 45.31 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -2.17 | -23.71 | -64.04 | -12.98 | Upgrade
|
| Other Investing Activities | - | 24.4 | -23.55 | - | - | Upgrade
|
| Investing Cash Flow | - | 9.9 | -124.08 | -137.13 | -91.91 | Upgrade
|
| Long-Term Debt Issued | - | 210 | 234.8 | - | 49.18 | Upgrade
|
| Long-Term Debt Repaid | - | -197.34 | -115.75 | -13.02 | -11.8 | Upgrade
|
| Net Debt Issued (Repaid) | - | 12.66 | 119.05 | -13.02 | 37.38 | Upgrade
|
| Issuance of Common Stock | - | 0.03 | 0.09 | 0.7 | 2,140 | Upgrade
|
| Other Financing Activities | - | -12.42 | -6.79 | -18.3 | -27.3 | Upgrade
|
| Financing Cash Flow | - | 0.28 | 112.35 | -30.62 | 2,859 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 10.81 | 97.39 | -67.25 | -130.78 | Upgrade
|
| Net Cash Flow | - | -377.43 | -451.06 | -796.2 | 2,376 | Upgrade
|
| Free Cash Flow | - | -410.83 | -613.6 | -634.29 | -385.24 | Upgrade
|
| Free Cash Flow Margin | - | -236.30% | -421.13% | -2059.57% | - | Upgrade
|
| Free Cash Flow Per Share | - | -1.00 | -1.50 | -1.59 | -2.92 | Upgrade
|
| Cash Interest Paid | - | 12.42 | 6.79 | 5.91 | 5.24 | Upgrade
|
| Levered Free Cash Flow | - | -218.11 | -428.1 | -575.04 | -168.34 | Upgrade
|
| Unlevered Free Cash Flow | - | -210.35 | -423.86 | -573.36 | -167.86 | Upgrade
|
| Change in Net Working Capital | 49.93 | -25.78 | 57.12 | 91.5 | -103.93 | Upgrade
|
Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.